ArticleBMC cardiovascular disorders2025
Incidence and burden of myocarditis in the Middle East and North Africa: a secondary analysis of global burden of diseases study 2019.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMyocarditis poses significant challenges in diagnosis and management due to its diverse etiology and clinical manifestations. Despite advances in medical care, myocarditis remains a leading cause of heart failure and sudden cardiac death worldwide, necessitating comprehensive understanding of its regional burden. This study aims to assess the incidence and burden of myocarditis in the Middle East and North Africa (MENA) region.
methodsData were obtained from the Global Burden of Diseases Study 2019, utilizing standardized disease criteria and statistics collected by the Institute of Health Metrics and Evaluation (IHME). Global, regional, and national estimates of myocarditis mortality, incidence, and disability-adjusted life years (DALYs) were gathered for the period from 1990 to 2019. The Socio-demographic Index (SDI) was utilized as a measure of national development.
resultsThe findings indicate a minor change in the age-standardized incidence rate (ASIR) of myocarditis over the three decades, while a notable decrease was observed in both the age-standardized mortality rate (ASMR) and age-standardized disability-adjusted rate (ASDR). Females exhibited higher ASMR and ASDR compared to males, despite similar ASIR trends. Country-level variations in myocarditis incidence were observed, with some nations experiencing increased rates, while others witnessed declines. Oman, Iraq, and Egypt had the highest ASMRs, whereas Bahrain, Jordan, and Turkey had the lowest.
conclusionThis study underscores the need for targeted interventions to mitigate the burden of myocarditis in the MENA region. The observed disparities in incidence and mortality rates highlight the complex interplay between socio-demographic factors and disease outcomes, emphasizing the importance of comprehensive public health strategies tailored to regional contexts. Further research is warranted to elucidate the underlying factors driving these disparities and inform effective intervention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.